Stralsund

Germany

15 total trials 6 recruiting

Filter these 15 trials by phase, condition, sponsor and more.

Open in Search →

Dehydroepiandrosterone (DHEA) as augmentation of standard antidepressants in treatment-resistant depression: a randomized controlled trial ( … Pending

2024-517963-21-00 5 Treatment Resistant Depression (TRD)
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 5 2025-08-21 Bronchiectasis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 5 2024-07-15 Progressive Pulmonary Fibrosis
Phase 3, Open-label Study of ARV-471 (PF-07850327) vs Fulvestrant in Participants With ER(+)/ HER2(-) Advanced Breast Cancer (VERITAC-2) Recruiting

2022-500544-38-00 5 2023-06-05 Advanced Breast Cancer
Evaluation of Niraparib alone compared to the combination of Niraparib and Bevacizumab in patients receiving chemotherapy for newly diagnose … Recruiting

2024-516066-11-00 5 2022-08-31 Patients with newly diagnosed, histologically confirmed, primary advan
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting

2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCE … Recruiting

2022-500764-35-00 6 2022-10-13 Patients with advanced HER2-negative, hormone receptor positive (HER2n
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended recruitment

2022-501024-20-00 5 2023-07-25 ER+/HER2- Early Breast Cancer
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit … Ended recruitment

2024-511209-49-00 6 2022-04-26 Patients with hormone receptor positive HER2 negative locally advanced
Clinical trial comparing Trastuzumab Deruxtecan with Trastuzumab Emtansine in high-risk HER2-positive patients with residual breast cancer f … Ended recruitment

2023-507961-24-00 5 2021-04-19 High-Risk HER2-Positive Breast Cancer
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 4 2024-09-10 Progressive pulmonary fibrosis (PPF)
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o … Ended

2022-500538-27-00 10 2023-03-30 Adjunctive therapy to antidepressants for the treatment of major depr
Pragmatic, randomized, multicentric, double-blind, controlled clinicial trial on the treatment of acute gout attacks with prednisolone versu … Ended

2024-514738-18-00 6 2023-01-12 gout, acute gout attack
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 5 2022-10-05 Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati … Ended

2023-508472-11-00 5 2018-06-13 Patients with early breast cancer

Showing 1–15 of 15 trials